Lupin Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Quarterly Results    (LUPL)

Here are the latest quarterly results of Lupin. For more details, see the Lupin financial fact sheet and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Lupin Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m45,04944,06344,18443,59737,69338,45735,27938,350 
Other income Rs m4348657221,3339362,086433250 
Turnover Rs m45,48344,92844,90644,92938,62940,54335,71138,600 
Expenses Rs m37,52335,34035,58236,28633,40233,20430,39832,538 
Gross profit Rs m4,1038,6778,6051,8461,4046,0844,8815,812 
Depreciation Rs m2,7982,8083,1713,2152,5322,1432,1462,127 
Interest Rs m7988558568658861,074443336 
Profit before tax Rs m9425,8795,300-901-1,0784,9542,7253,598 
Tax Rs m2,4782,9982,2803437,6701,0511,6431,467 
Profit after tax Rs m-1,5362,8813,021-1,244-8,7483,9031,0812,131 
Gross profit margin %9.119.719.54.23.715.813.815.2 
Effective tax rate %263.051.043.0-38.1-711.421.260.340.8 
Net profit margin %-3.46.56.8-2.9-23.210.13.15.6 
Diluted EPS Rs -3.4 6.4 6.7 -2.7 -19.3 8.6 2.4 4.7  
Diluted EPS (TTM) Rs 13.5 13.4 15.6 6.9 -9.0 -6.8 -11.1 -3.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Lupin 2QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH  FULFORD INDIA  BIOCON   

Compare LUPIN With:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH  FULFORD INDIA  BIOCON   

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Indian Share Markets Closed at Record High Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Views on news

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Dec 4, 2020 (Close)

TRACK LUPIN

LUPIN - NEULAND LABS COMPARISON

COMPARE LUPIN WITH

MARKET STATS